menu title
MWAETC On-Demand: HIV Treatment
-
Review of a clinical study on initiating ART in early HIV
-
Indications for Resistance Testing, Basics of Stanford Univ HIV Drug…
-
Selected Abstracts from the 2023 CROI Conference
-
Selected Abstracts from the 2023 CROI Conference
-
Discussion of use of LAI ART for persons with detectable viral loads
-
-
Opportunistic infections and ART guidelines updates
-
Evaluation and Management of persistent viremia in PWH taking ART
-
-
-
-
Review of the DAWNING trial and the NADIA trial
-
HIV Treatment Guidelines
-
Injectable ART for those with detectable viral loads
-
Data on the newly approved medication Lenacapavir
-
Review of historic and recent data on cardiovascular risk
-
Review of studies on HIV prevention, treatment and co-morbidities…
-
-
Update on treatment guidelines, new agents, and what's in the pipeline
-
When and how to initiate treatment and establish care for patients newly…
-
Best practices for linking, engaging, and retaining youth with HIV (YWH)…
-
The "how to" of using Cabotegravir/Rilpivirine in your clinic
-
Review of HIV treatment studies presented at the CROI 2022 conference
-
Overview of the ART decision-making tool, ASSIST
